Published in Women's Health Weekly, March 24th, 2005
"Prospective studies show that high serum levels of androgens and estrogens are associated with increased incidence of postmenopausal breast cancer. The aim of the present analysis was to study the prognostic value of serum testosterone, estradiol, and related factors in postmenopausal breast cancer patients," said F. Berrino and colleagues, Istituto Nazionale Tumori, Milan.
Of 110 patients, follow-up of 5.5 years found that "31 patients developed distant metastasis (16), local relapse (4), or contralateral breast cancer (11)."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.